Stay updated on IcoSema vs. Semaglutide in Type 2 Diabetes Clinical Trial
Sign up to get notified when there's something new on the IcoSema vs. Semaglutide in Type 2 Diabetes Clinical Trial page.

Latest updates to the IcoSema vs. Semaglutide in Type 2 Diabetes Clinical Trial page
- Check3 days agoChange DetectedThe record’s revision label was updated from v3.6.0 to v3.6.2. This indicates a new revision of the study record.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedA new revision (v3.6.0) on 2026-05-25 added the Contacts/Locations and Study Status sections, and a subsequent 2026-06-12 entry notes that the study is no longer looking for participants. An older revision (v3.5.5) was removed on 2025-07-09.SummaryDifference1%

- Check24 days agoChange DetectedA new revision entry v3.5.5 was added to the revision history, and the earlier revision v3.5.4 was removed, updating the page's versioning metadata.SummaryDifference0.1%

- Check46 days agoChange DetectedThe header shows Revision: v3.5.4, replacing the prior Revision: v3.5.3, indicating a new build of the page interface.SummaryDifference0.1%

- Check67 days agoChange DetectedThe page’s displayed interface/version label has been updated from Revision v3.5.2 to Revision v3.5.3, indicating a platform UI release rather than a change to the underlying trial record.SummaryDifference0.1%

- Check74 days agoChange DetectedA new Revision: v3.5.2 was added to the history, replacing the previous Revision: v3.5.0.SummaryDifference0.1%

Stay in the know with updates to IcoSema vs. Semaglutide in Type 2 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IcoSema vs. Semaglutide in Type 2 Diabetes Clinical Trial page.